Increase in prevalence of diseases, such as cardiac disorders, blood pressure, cancer; and increase in road accidents drive the market growth. In addition, growth in surgical procedures, rise in trauma cases, rapid technological advancements, increase in awareness among the population, and surge in geriatric population fuel the market further. However, high risk of allergic reaction is expected to restrain the growth of the market during the forecast period. The global intravenous therapy and vein access market has accounted for $18,000 million in 2016, and is estimated to reach $27,971 million by 2023, growing at a CAGR of 6.4% during the forecast period.
The market is segmented on the basis of product type, medical application, end user, and geography. By product type, it is categorized into implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and other products. Medical applications covered in the study include volume expanders, medication administration, blood-based products, and nutrition & buffer solution. Based on end user, it is classified into hospitals, ambulatory surgical centers, and clinics. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STKEHOLDERS
The study provides an in-depth analysis of the global intravenous therapy and vein access market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly to predict the competitive outlook of the market.
KEY MARKET SEGMENTS
Single Lumen Implantable Port
Double Lumen Implantable Port
Peripheral Intravenous Catheter
Central Intravenous Catheter
Peripherally Inserted Central Catheter
By Medical Application
Nutrition & Buffer Solution
By End User
Ambulatory Surgical Centers
Rest of Europe
Rest of Asia-Pacific
List of players profiled in the report
Becton, Dickinson and Company
B. Braun Melsungen AG
Terumo Medical Corporation
Teleflex Medical Inc.
Smith & Nephew plc.
Fresenius SE & Co. KGaA
List of other players (These companies are not profiled in the report and same can be done on demand)
Baxter International Inc.
JW Life Science Co. Ltd.
BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd.
CVS Health Corporation
Vifor Pharma Group
1.3.KEY MARKET SEGMENT
1.4.3.Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1.KEY FINDINGS OF THE STUDY
CHAPTER 3 MARKET OVERVIEW
3.1.MARKET DEFINITION AND SCOPE
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.PORTERS FIVE FORCES ANALYSIS
3.3.1.Bargaining power of buyers
3.3.2.Bargaining power of suppliers
3.3.3.Threat of substitutes
3.3.4.Threat of new entrants
3.4.TOP PLAYERS POSITIONING, 2016
126.96.36.199.Increase in geriatric population
188.8.131.52.Increase in prevalence of chronic diseases
184.108.40.206.Increase in trauma cases and traffic accidents
220.127.116.11.Wide advantages of IV therapy and vein access devices
18.104.22.168.Risk of allergic reaction and requirement of skilled professionals
22.214.171.124.Stringent government regulations
126.96.36.199.Lucrative opportunities from emerging economies
CHAPTER 4 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY TYPE
4.1.1.Market size and forecast
4.2.1.Key market trends
4.2.2.Key growth factors and opportunities
4.2.3.Market size and forecast
4.2.4.Single Lumen Implantable Port
188.8.131.52.Market size and forecast
4.2.5.Double Lumen Implantable Port
184.108.40.206.Market size and forecast
4.3.1.Key market trends
4.3.2.Key growth factors and opportunities
4.3.3.Market size and forecast
4.3.4.Peripheral Intravenous Catheter
220.127.116.11.Market size and forecast
4.3.5.Central Intravenous Catheter
18.104.22.168.Market size and forecast
4.3.6.Peripherally Inserted Central Catheter
22.214.171.124.Market size and forecast
4.4.1.Key market trends
4.4.2.Key growth factors and opportunities
4.4.3.Market size and forecast
4.5.1.Key market trends
4.5.2.Key growth factors and opportunities
4.5.3.Market size and forecast
4.6.1.Key market trends
4.6.2.Key growth factors and opportunities
4.6.3.Market size and forecast
CHAPTER 5 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY MEDICAL APPLICATION
5.1.1.Market size and forecast
5.2.1.Market size and forecast
5.3.1.Market size and forecast
5.4.BLOOD BASED PRODUCTS
5.4.1.Market size and forecast
5.5.NUTRITION AND BUFFER SOLUTION
5.5.1.Market size and forecast
CHAPTER 6 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY END-USER
6.1.1.Market size and forecast
6.2.1.Market size and forecast
6.3.AMBULATORY SURGICAL CENTERS
6.3.1.Market size and forecast
6.4.1.Market size and forecast
CHAPTER 7 IV THERAPY & VEIN ACCESS DEVICES MARKET, BY GEOGRAPHY
7.1.1.Market size and forecast
7.2.1.Key market trends
7.2.2.Key growth factors and opportunities
7.2.3.Market size and forecast
7.2.4.U.S. market size and forecast
7.2.5.Canada market size and forecast
7.2.6.Mexico market size and forecast
7.3.1.Key market trends
7.3.2.Key growth factors and opportunities
7.3.3.Market size and forecast
7.3.4.Germany market size and forecast
7.3.5.France market size and forecast
7.3.6.UK market size and forecast
7.3.7.Italy market size and forecast
7.3.8.Spain market size and forecast
7.3.9.Rest of Europe market size and forecast
7.4.1.Key market trends
7.4.2.Key growth factors and opportunities
7.4.3.Market size and forecast
7.4.4.Japan market size and forecast
7.4.5.China market size and forecast
7.4.6.India market size and forecast
7.4.7.Rest of Asia-Pacific market size and forecast
7.5.1.Key market trends
7.5.2.Key growth factors and opportunities
7.5.3.Market size and forecast
7.5.4.Latin America market size and forecast
7.5.5.Middle East market size and forecast
7.5.6.Africa market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1.BECTON, DICKINSON AND COMPANY
8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4. Key Strategic Moves & Developments
8.2. B.BRAUN MELSUNGEN AG
8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4.Key Strategic Moves & Developments
8.3.TERUMO MEDICAL CORPORATION
8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4.Key Strategic Moves & Developments
8.4.TELEFLEX MEDICAL INC.
8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4.Key Strategic Moves & Developments
8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4. Key Strategic Moves & Developments
8.6.SMITH & NEPHEW PLC.
8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4.Key Strategic Moves & Developments
8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4.Key Strategic Moves & Developments
8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.4. Key Strategic Moves & Developments
8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4. Key Strategic Moves & Developments
8.10.FRESENIUS SE & CO. KGAA
8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4. Key Strategic Moves & Developments
Intravenous therapy is used to administer medicine, nutrients, blood, and buffer solution directly into the vein. IV therapy works faster for the quick immune system response and relief from chronic diseases as compared to oral mode of medication. IV therapy can be easily monitored and has infusion pump that controls the volume of the substance to be administered in the body. Increase in incidence of chronic disorders, surge in trauma cases, rise in geriatric population, and growth in road accidents are expected to boost the market growth during the analysis period. However, lack of skilled professionals is projected to restrain the market growth during the forecast period.
The intravenous catheter market segment held the highest share in 2016, owing to increase in healthcare expenditure and continuous advancement in intravenous catheter technology, which are expected to support the growth of this market during the forecast period.
Medical administration held the highest market share in 2016, owing to wide use of IV therapy for medication administration as it is most effective, fast acting, and suitable for unconscious and emergency patients. The hospitals segment gained the highest market share in 2016, owing to highest number of surgical procedures in hospitals resulting in usage of IV therapy.
North America accounted for two-fifths share in 2016, and is expected to dominate the market throughout the forecast period. This is attributed to increase in incidence of chronic diseases due to rise in geriatric population, well-established healthcare systems, and increase in awareness among the population toward timely diagnosis and treatment of diseases. In addition, higher adoption rate for technologically advanced devices is anticipated to provide new growth opportunities for the key players in the market. However, Asia-Pacific is projected to grow at the highest growth rate during the analysis period, owing to rise in healthcare expenditure, increase in per capita income, growth in demand for healthcare services from large pool of patient population, and improvement in healthcare infrastructure.
Key Findings of the Intravenous Therapy and Vein Access Devices Market:
By product, the intravenous catheter segment dominated the market in 2016, and is projected to grow at the highest CAGR during the analysis period 2017-2023.
By application, the medication administration segment accounted for the highest share in 2016.
U.S. was the major shareholder in the North America IV therapy and vein access devices market in 2016.
Asia-Pacific is expected to witness the highest growth rate.
China is expected to grow at the highest CAGR in the Asia-Pacific IV therapy and vein access devices market in 2016.
The major players profiled in the global IV therapy and vein access devices market are Becton, Dickinson and Company, B. Braun Melsungen AG, Terumo Medical Corporation, Teleflex Medical Inc., Medtronic Inc., Smith & Nephew plc., AngioDynamics, Inc., Pfizer Inc., Insulet Corporation, and Fresenius SE & Co. KGaA.
- Becton, Dickinson And Company
- B. Braun Melsungen Ag
- Terumo Medical Corporation
- Teleflex Medical Inc.
- Medtronic Inc.
- Smith & Nephew Plc.
- Angiodynamics, Inc.
- Pfizer Inc.
- Insulet Corporation
- Fresenius Se & Co. Kgaa
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.